Browse > Article

A case of acute respiratory distress syndrome treated with surfactant and low dose methylprednisolone  

Choi, Bo Yeon (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Kim, Kyong Mo (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Yoon, Jong Seo (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Lee, Joon Sung (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Publication Information
Clinical and Experimental Pediatrics / v.49, no.4, 2006 , pp. 455-459 More about this Journal
Abstract
The major pathogenesis of acute respiratory distress syndrome (ARDS) is an inflammatory process that results from a diversity of injuries to the body. Due to the various cytokines and vasoactive peptides released from the endothelium, the vascular permeability is increased; the migration of inflammatory cells and the leakage of plasma proteins then occur and edema develops in the alveolus. There is a hypothesis that the impairment of alveolar recruitment in ARDS is caused by a defect of the surfactant system and the resultant increase of alveolar surface tension. This has been studied in pediatric patients in ARDS; after the administration of surfactant, hypoxia, respiratory symptoms and survival chances were improved. To alleviate the major pathogenic mechanism in this disease, that is to say, inflammation of the lung, steroids have been used and studied as another treatment modality for ARDS, and it has been concluded that the administration of low dose methylprednisolone may improve patients' symptoms and survival rates. We report here on a case of a young infant admitted with ARDS, who, after the intratracheal administration of 120 mg/kg surfactant, on $PaO_2/FiO_2$ was elevated. Subsequent low doses of methylprednisolone were given, and the symptoms did not recur, and no fibrotic change was shown during the follow-up period of 2 months.
Keywords
Acute respiratory distress syndrome; Surfactant; MethylprednisoloneIntroduction;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Zilberberg MD, Epstein SK. Acute lung injury in the medical ICU : co-morbid conditions, age, etiology, and hospital outcome. Am J Respir Crit Care Med 1998;157:1159-64   DOI   ScienceOn
2 Willson DF, Thomas NJ, Markovitz BP, Bauman LA, Dicarlo JV, Pon S, et al. Effect of exogenous surfactant (carfactant) in pediatric acute lung injury : a randomized controlled trial. JAMA 2005;293:470-6   DOI   ScienceOn
3 Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;2:319-23
4 Ware LB, Matthay MA. The acute respiratory distress syndrome. New Engl J Med 2000;342:1334-49   DOI   ScienceOn
5 Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 1997;77:931-62   DOI
6 Herting E, Gan X, Rauprich P, Jarstrand C, Robertson B. Combined treatment with surfactant and specific immunoglobulin reduces bacterial proliferation in experimental neonatal group B strepsococcal pneumonia. Am J Resip Crit Care Med 1999;159:1862-7   DOI   ScienceOn
7 Luce JM, Montgomery AB, Markers JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988;138:62-8   DOI   ScienceOn
8 Bernard GR, Artigas KL, Carlet J, Falke K, Hudson L, Lamy M, et al. Report of the American-European Consensus conference on acute respiratory distress syndrome : definition, mechanism, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care 1994;9:72-81   DOI   ScienceOn
9 Molijn GJ, Spek JJ, van Uffelen JC, de Jong FH, Brinkmann AO, Bruining HA, et al. Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes in patients with sepsis or septic shock. J Clin Endocrinol Metab 1995;80:1799-803   DOI
10 Gregory TJ, Steinberg KP, Spragg R, Gadek JE, Hyers TM, Longmore WJ, et al. Bovine surfactant theraphy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997;155:1309-15   DOI
11 Anzueto A, Baughman R, Guntupalli KK, Weg JG, Wiedermann HP, Raventos AA, et al. Aerosolized surfactants in adults with sepsis induced acute respiratory distress syndrome. N Engl J Med 1996;334:1417-21   DOI   ScienceOn
12 Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelson T, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome : a randomized controlled trial. JAMA 1998;280:159-65   DOI   ScienceOn
13 Kallet RH, Jasmer RM, Pittet JF, Tang JF, Campbell AR, Dicker R, et al. Clinical implementation of the ARDS network protocol is associated with reduced hospital mortality compared with historical controls. Crit Care Med 2005;33: 925-9.   DOI   ScienceOn
14 Falke KJ, Pontoppidan H, Kumar A, Leith DE, Geffin B, Laver MB. Ventilation with end-expiratory pressure in acute lung disease. J Clin Invest 1972;51:2315-23   DOI
15 Gunther A, Ruppert C, Schmidt R, Markart P, Grimminger F, Walmrath D, et al. Surfactant alteration and replacement in acute respiratory distress syndrome. Respir Res 2001;2: 353-64   DOI
16 Rothwell PM, Udwadia ZF, Lawler PG. Cortisol response to corticotropin and survival in septic shock. Lancet 1991;337: 582-3   DOI   ScienceOn
17 Meduri GU, Tolley EA, Chinn A, Stentz F, Postlethwaite A. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med 1998;158:1432-41   DOI   ScienceOn
18 The Acute Respiratory Distress Syndrome Network. Ventilation with low tidal volume as compared with traditional tidal volume. N Engl J Med 2000;342:1301-8   DOI   ScienceOn
19 MacCallum NS, Evans TW. Epidemiology of acute lung injury. Curr Opin Crit Care 2005;11:43-9   DOI   ScienceOn
20 Gattinoni L, Presenti A, Bombino M, Baglioni S, Rivolta M, Rossi F, et al. Relationships between lung computed tomographic density, gas exchange, and PEEP in acute respiratory failure. Anesthesiology 1988;69:824-32   DOI   ScienceOn